|
1.
Share Success: Letters From Readers
Letter
I: From Chris P.
Received
at Share Success Tuesday, October 9, 2018, 10:54 AM PDT
(Unedited)
I never write testimonials but in this case one is overdue.
A few years ago I was told I had arthritis in the joints of my large toes. It's called Hallux Limitus. I saw a podiatrist who made custom orthotics for me but he said to expect it to get worse.
I couldn't accept that as it meant eventual surgeries leading to the awful prospect of ultimately having my joints fused. I'm a very active person and this just wasn't acceptable to me so I started searching for other options.
One of the issues I had with this arthritis was bone spurs. You could feel them below the skin near the joints. So I searched for solutions to bone spurs and found Ezorb Calcium. I figured what the heck… I'd give it a try.
Well, in about 6 months I noticed I couldn't feel those bumps any longer. The bone spurs were gone! I've continued taking Ezorb and not only have the bone spurs not returned, I'm back to being able to wear sandals again.
I still use the orthotics and good quality shoes, and I do daily toe exercises too, but I credit Ezorb with really making all the difference in arresting the arthritis and allowing me to have hope that I will avoid surgeries.
I sing the praises of this calcium to everyone I meet who suffers from any sort of bone or joint issue. It works! Thank you Ezorb! (Oh and I really love their customer service too. Great people!)
Chris P.
(Address)
(Phone 1)
(Phone 2)
Letter II: From Laura
Received
at Testimonial Submit Form Saturday, September 22, 2018 at 18:20:15
(Unedited)
Hi, my name is Laura. I was diagnosed with osteoporosis earlier this year.
My doctor put me on Fosamax. The first and only pill I took did okay during the day, but when I laid down to go to sleep that night, the pain started coming on quickly. And soon, I was in so much pain I couldn't move. I couldn't even breathe, it hurt so bad.
The rest of that week and into the next week, I was in so much pain, I still could hardly breathe. I called my doctor and said I would never taking that medicine again.
I then got online to see if there could be an alternative. EZorb came up, and I read extensively on it. So I decided to give it a try. I have now been on it for about a week. From the first day I was on it, I have had very little pain.
I love this stuff! I am staying on it for as long as it keeps on working. Yay!
***************************************************
From
the Desk of EZorb Newsletter Editor:
This
newsletter is now read by over 95,000 subscribers
worldwide. Success stories you have contributed over
the years have had a great impact on many people's
quality of life. Your continuous support will be
greatly appreciated by tens of thousands who have been
suffering and would continuously suffer, without your
help! Please email your
story to sharesuccess @ ezorbonline.com
or simply post it at Testimonial
Submit Form. Your personal information will never be
revealed to the public. We appreciate your effort.
2.
Research News: Gastric Bypass Good or Bad for Type 2 Diabetes Patients?
Overweight and obese patients with type 2 diabetes who undergo gastric bypass have significantly lower risks for death, cardiovascular disease (CVD), and severe kidney disease than those who do not have such surgery, Swedish research shows.
They are also at significantly increased risk for both short- and long-term complications, however.
Vasileios Liakopoulos (University of Gothenburg) and colleagues report that during an average follow-up of 4.5 years, the risk for all-cause mortality was a significant 49% lower among 5321 patients with type 2 diabetes who underwent Roux-en-Y gastric bypass than among 5321 patients who also had type 2 diabetes and were matched for sex, age, BMI, and time period, but did not undergo surgery.
The incidence rates for all-cause mortality were 72.9 and 142.1 per 10,000 person-years in the gastric bypass and control groups, respectively.
Patients who underwent surgery also had a significant 42% lower risk for severe kidney disease (42.4 vs 76.9 events per 10,000 person-years) and a 34% lower risk for CVD (43.5 vs 61.5 events per 10,000 person-years), as well as significantly lower risks for hospitalization for hyperglycemia (hazard ratio HR=0.33), leg amputation (HR=0.51), and cancer (HR=0.78).
The disadvantages of gastric bypass included a significant 3.3-fold higher risk for additional gastric surgery, likely due to the higher risks for bowel obstruction (HR=9.5), bleeding (HR=6.9), abdominal pain (HR=5.5), gastrointestinal leakage (HR=5.5), and gastrointestinal ulcers and reflux (HR=5.4), as well as wound complications (HR=3.5), hernia (HR=2.8) and gallstones, gallbladder disease, or pancreatitis (HR=2.5).
In the long term, patients who underwent gastric bypass had significant 2.8- and 1.9-fold higher risks for malnutrition and anemia, respectively, and also a 1.3-fold higher risk for hospitalization for psychiatric disorders.
This particular finding indicates that "greater awareness is needed in order to identify vulnerable patients with a history of self-harm or depression who may need psychiatric services after gastric bypass," Liakopoulos et al remark.
They also note that, in line with previous data, patients who underwent gastric bypass were at significantly higher risk for alcohol-related problems that lead to hospitalization than those who did not, at an HR of 2.9, which the team says highlights "the importance of careful selection of patients who are offered surgery, as well as better follow-up of those with a history of alcohol-related risk behavior."
Writing in BMJ Open, Liakopoulos and co-authors point out that their study only included events that were diagnosed during hospitalization, not outpatient care. "Comorbidities and incidence of postoperative outcomes may be underestimated as a result," they say.
The researchers conclude that "to maximize the benefit and minimize the risk of problems [associated with gastric bypass], long-term postoperative monitoring and support should be provided."
They add: "Better selection of patients for such treatment, performed by appropriate specialists in interdisciplinary settings, could probably also optimize outcomes."
Original article appeared in Original article was published in 01-16-2019 | Obesity | News.
3.
Useful Links
Frequently
Asked Questions & Answers
EZorb
Clinical Studies
Marvlix
Benefits
Order
Now
4.
Calcium
Absorption Test
EZorb
Calcium has set a new world record of absorption rate.
You can compare EZorb with other calcium supplements
by using the simple step-by-step instructions we
provide. E-mail your request to test @ elixirindustry.com
for a copy of the instructions.
5.
What Are Others Saying About EZorb and Marvlix?
EZorb and Marvlix have restored confidence in thousands of men
and women. It has brought happiness and healthy life
to families around the world. Click here
to read what people say about EZorb and Marvlix. |
